Related Experiment Video
Updated: Jun 27, 2025

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
The role of ZC3H12D-regulated TLR4-NF-κB pathway in LPS-induced pro-inflammatory microglial activation
Jinyun Long1, Xiukuan Li1, Chunyan Yao2
1School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang 561113, China; Department of Epidemiology, College of Preventive Medicine, State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University (Third Military Medical University), Chongqing 400038, China.
Abstract:
Lipopolysaccharide (LPS) is an important neurotoxin that can cause inflammatory activation of microglia. ZC3H12D is a novel immunomodulator, which plays a remarkable role in neurological pathologies. It has not been characterized whether ZC3H12D is involved in the regulation of microglial activation. The aim of this study was to investigate the role of ZC3H12D in LPS-induced pro-inflammatory microglial activation and its potential mechanism. To elucidate this, we established animal models of inflammatory injury by intraperitoneal injection of LPS (10 mg/kg). The results of the open-field test showed that LPS caused impaired motor function in mice. Meanwhile, LPS caused pro-inflammatory activation of microglia in the mice cerebral cortex and inhibited the expression of ZC3H12D. We also constructed in vitro inflammatory injury models by treating BV-2 microglia with LPS (0.5 μg/mL). The results showed that down-regulated ZC3H12D expression was associated with LPS-induced pro-inflammatory microglial activation, and further intervention of ZC3H12D expression could inhibited LPS-induced pro-inflammatory activation of microglia. In addition, LPS activated the TLR4-NF-κB signaling pathway, and this process can also be reversed by promoting ZC3H12D expression. At the same time, the addition of resveratrol, a nutrient previously proven to inhibit pro-inflammatory microglial activation, can also reverse this process by increasing the expression of ZC3H12D. Summarized, our data elucidated that ZC3H12D in LPS-induced pro-inflammatory activation of brain microglia via restraining the TLR4-NF-κB pathway. This study may provide a valuable clue for potential therapeutic targets for neuroinflammation-related injuries.
Insights
Lipopolysaccharide (LPS) triggers neuroinflammation by activating microglia. This study reveals ZC3H12D inhibits this activation by targeting the TLR4-NF-κB pathway, offering therapeutic potential for neuroinflammation.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Lipopolysaccharide (LPS) is a potent neurotoxin known to induce microglial activation and neuroinflammation.
- ZC3H12D is an emerging immunomodulator with potential roles in neurological conditions, but its specific involvement in microglial activation remained uncharacterized.
Purpose of the Study:
- To investigate the role of ZC3H12D in regulating lipopolysaccharide (LPS)-induced pro-inflammatory microglial activation.
- To elucidate the underlying molecular mechanisms by which ZC3H12D influences microglial responses to LPS.
Main Methods:
- Establishment of animal models using intraperitoneal LPS injection to assess motor function and cerebral microglial activation.
- In vitro studies using BV-2 microglia treated with LPS to analyze ZC3H12D expression and its impact on inflammatory pathways.
- Investigation of the Toll-like receptor 4 (TLR4)-nuclear factor-kappa B (NF-κB) signaling pathway and the effect of ZC3H12D and resveratrol.
Main Results:
- LPS administration impaired motor function and induced pro-inflammatory microglial activation in mice, accompanied by decreased ZC3H12D expression.
- In vitro, reduced ZC3H12D expression correlated with LPS-induced microglial activation; enhancing ZC3H12D expression inhibited this activation.
- LPS-induced activation of the TLR4-NF-κB pathway was reversed by promoting ZC3H12D expression, an effect also observed with resveratrol.
Conclusions:
- ZC3H12D plays a critical role in suppressing LPS-induced pro-inflammatory activation of microglia in the brain.
- ZC3H12D exerts its neuroprotective effects by inhibiting the TLR4-NF-κB signaling pathway.
- ZC3H12D represents a potential therapeutic target for mitigating neuroinflammation and related neurological injuries.
More Related Videos
11:29Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
Published on: July 17, 2016
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...